Latest Articles
Drugs like Ozempic show promise for more than weight loss. But what’s the science? - Daily Maverick
Drugs like Ozempic show promise for more than weight loss. But what’s the science? Daily Maverick
Published: June 30, 2026, 1:01 p.m.
Groundbreaking Menstrual Blood Diagnostic Test Promises Non-Invasive Endometriosis Detection Alternative - streamlinefeed.co.ke
Groundbreaking Menstrual Blood Diagnostic Test Promises Non-Invasive Endometriosis Detection Alternative streamlinefeed.co.ke
Published: June 26, 2026, 7:45 a.m.
GLP‑1 drugs like Ozempic show promise for more than weight loss, but what's science vs. hype? - Medical Xpress
GLP‑1 drugs like Ozempic show promise for more than weight loss, but what's science vs. hype? Medical Xpress
Published: June 2, 2026, 6 p.m.
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity - Nature
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity Nature
Published: June 2, 2026, 3:03 p.m.
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype? - The Conversation
GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype? The Conversation
Published: June 2, 2026, 5 a.m.
Weight loss drugs show promise in breast cancer fight — plus more medical headlines - AOL.com
Weight loss drugs show promise in breast cancer fight — plus more medical headlines AOL.com
Published: May 30, 2026, 9:02 a.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com UK
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com UK
Published: May 21, 2026, 8:34 p.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com
Published: May 21, 2026, 2:57 p.m.
Malta’s sexual health strategy: Repackaging old promises - MaltaToday
Malta’s sexual health strategy: Repackaging old promises MaltaToday
Published: May 20, 2026, 4 a.m.
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer - TradingView
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer TradingView
Published: May 19, 2026, 2 p.m.
Link copied to clipboard!